Post-infectious irritable bowel syndrome after a laboratory-proven enteritis

被引:11
|
作者
Iacob, Teodora [1 ]
Tatulescu, Doina F. [1 ]
Lupse, Mihaela S. [1 ]
Dumitrascu, Dan L. [2 ]
机构
[1] Iuliu Hatieganu Univ Med & Pharm, Dept Infect Dis, Cluj Napoca 400348, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Med Dept 2, 3-6 Clinicilor St, Cluj Napoca 400006, Romania
关键词
post-infectious irritable bowel syndrome; acute infectious gastroenteritis; laboratory; microbiology; coproparasitological examination; enzyme-linked fluorescent assay; CLOSTRIDIUM-DIFFICILE INFECTION; BACTERIAL GASTROENTERITIS; RISK-FACTORS; PREVALENCE; OUTBREAK; DIARRHEA; EPIDEMIOLOGY; PROBIOTICS; DISORDERS; DYSPEPSIA;
D O I
10.3892/etm.2020.9018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
There are scarce data on risk factors for post-infectious irritable bowel syndrome (PI-IBS). The objective of this study was to determine the risk factors of developing PI-IBS following an acute infectious gastroenteritis (AGE) episode in which, by laboratory tests, the etiological agent was isolated. The study was conducted on patients admitted to a tertiary center of infectious diseases during three consecutive years. The patients were divided into two groups: a group consisting of patients admitted with AGE (with an isolated etiological agent) and a control group consisting of patients admitted for an acute upper respiratory tract infection (URTI). The subjects were recalled in our center 6 months after the admission and were evaluated with Rome III IBS diagnostic questionnaire and Bristol Stool Form Scale. The questionnaires were paper printed and directly filled in by the subjects. The response rate in the case group was 5% and in the control group 100%. The prevalence of PI-IBS was higher in patients with AGE, presenting a relative risk (RR) of 4.16 [95% confidence interval (CI), 1.89-9.17], statistically significant (P<0.001) vs. URTI. From 28 female patients, 22 patients (79%) developed PI-IBS and from 17 male patients, 3 patients (18%) had developed PI-IBS with a risk of 4.4 (95% CI, 1.56-12.65), P<0.001. Regarding the infectious etiology of the AGE, Campylobacter jejuni had the highest risk of developing PI-IBS, RR=1.2 (95% CI, 0.13-3.11), P=0.04 compared with the other agents with a lower risk. The risk to develop PI-IBS after AGE infection is 4.16 higher than after URTI. Female sex is a risk factor for PI-IBS, 79% of the female patients developed PI-IBS after AGE. The incidence of PI-IBS is highest in patients with Campylobacter jejuni AGE compared with the other agents.
引用
收藏
页码:3517 / 3522
页数:6
相关论文
共 50 条
  • [31] Almost all irritable bowel syndromes are post-infectious and respond to probiotics: Consensus issues
    Cuomo, Rosario
    Savarese, Maria Flavia
    Gargano, Rosalba
    DIGESTIVE DISEASES, 2007, 25 (03) : 241 - 244
  • [32] Almost all irritable bowel syndromes are post-infectious and respond to probiotics: Controversial issues
    Barbara, Giovanni
    Stanghellini, Vincenzo
    Cremon, Cesare
    De Giorgio, Roberto
    Corinaldesi, Roberto
    DIGESTIVE DISEASES, 2007, 25 (03) : 245 - 248
  • [33] Post-Infectious Sequelae of Travelers’ Diarrhea: Reactive Arthritis, Guillain-Barré Syndrome, and Irritable Bowel Syndrome
    Connor B.A.
    Current Tropical Medicine Reports, 2016, 3 (3) : 102 - 107
  • [34] Postinfectious Irritable Bowel Syndrome After Campylobacter Infection
    Walter, Elaine J. Scallan
    Crim, Stacy M.
    Bruce, Beau B.
    Griffin, Patricia M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (10) : 1649 - 1656
  • [35] Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota
    Jin, Yu
    Ren, Xiaoyang
    Li, Gangping
    Li, Ying
    Zhang, Lei
    Wang, Huan
    Qian, Wei
    Hou, Xiaohua
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (02) : 443 - 452
  • [36] An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome
    Spiller, Robin
    Lam, Ching
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 18 (03) : 258 - 268
  • [37] The impact of atopic disease on the risk of post-infectious fatigue and irritable bowel syndrome 3 years after Giardia infection. A historic cohort study
    Hunskar, Gunnhild S.
    Langeland, Nina
    Wensaas, Knut-Arne
    Hanevik, Kurt
    Eide, Geir Egil
    Morch, Kristine
    Rortveit, Guri
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (8-9) : 956 - 961
  • [38] The proven and the new in the pharmacotherapy of irritable bowel syndrome
    Layer, Peter
    Andresen, Viola
    INNERE MEDIZIN, 2024, 65 (09): : 955 - 961
  • [39] Effect of Lactobacillus rhamnosus GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome
    Cao, Ya-Nan
    Feng, Li-Juan
    Liu, Yuan-Yuan
    Jiang, Kui
    Zhang, Mao-Jun
    Gu, Yi-Xin
    Wang, Bang-Mao
    Gao, Jia
    Wang, Ze-Lan
    Wang, Yu-Ming
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (03) : 338 - 350
  • [40] Impact of mechanical barrier damage and interleukin-17 on symptoms in patients with post-infectious irritable bowel syndrome
    Zhao, Jingdong
    Dai, Yinghuan
    Tian, Jie
    Lei, Ling
    Zhou, Xuchun
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (07)